This article has been updated to include comments from a conference call and a stock quote.
 
NEW YORK (GenomeWeb news) – Amid its split with sister company Celera and recently announced $6.7 billion merger with Invitrogen, Applied Biosystems reported today that its fourth-quarter revenues rose 9 percent.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.